- Home
- GRVY vs ORGO Comparison
GRVY vs ORGO Comparison
Compare GRVY & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRVY
- ORGO
- Stock Information
- Founded
- GRVY 2000
- ORGO 1985
- Country
- GRVY South Korea
- ORGO United States
- Employees
- GRVY N/A
- ORGO N/A
- Industry
- GRVY Business Services
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GRVY Consumer Discretionary
- ORGO Health Care
- Exchange
- GRVY Nasdaq
- ORGO Nasdaq
- Market Cap
- GRVY 442.6M
- ORGO 465.6M
- IPO Year
- GRVY 2005
- ORGO N/A
- Fundamental
- Price
- GRVY $65.04
- ORGO $4.89
- Analyst Decision
- GRVY
- ORGO Buy
- Analyst Count
- GRVY 0
- ORGO 2
- Target Price
- GRVY N/A
- ORGO $7.50
- AVG Volume (30 Days)
- GRVY 14.6K
- ORGO 642.5K
- Earning Date
- GRVY 08-08-2025
- ORGO 08-07-2025
- Dividend Yield
- GRVY N/A
- ORGO N/A
- EPS Growth
- GRVY N/A
- ORGO N/A
- EPS
- GRVY 8.59
- ORGO N/A
- Revenue
- GRVY $404,804,469.00
- ORGO $429,531,000.00
- Revenue This Year
- GRVY N/A
- ORGO $2.57
- Revenue Next Year
- GRVY N/A
- ORGO $9.80
- P/E Ratio
- GRVY $7.44
- ORGO N/A
- Revenue Growth
- GRVY N/A
- ORGO N/A
- 52 Week Low
- GRVY $53.12
- ORGO $2.46
- 52 Week High
- GRVY $70.00
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- GRVY 52.64
- ORGO 59.08
- Support Level
- GRVY $62.56
- ORGO $4.41
- Resistance Level
- GRVY $70.00
- ORGO $4.90
- Average True Range (ATR)
- GRVY 2.27
- ORGO 0.30
- MACD
- GRVY -0.06
- ORGO -0.03
- Stochastic Oscillator
- GRVY 44.89
- ORGO 92.58
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.